EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 148 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.35 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $230,000 | -10.2% | 4,300 | 0.0% | 0.01% | 0.0% |
| Q3 2017 | $256,000 | -25.4% | 4,300 | -1.1% | 0.01% | -37.5% |
| Q2 2017 | $343,000 | -2.6% | 4,350 | +2.4% | 0.01% | -11.1% |
| Q1 2017 | $352,000 | -10.2% | 4,250 | -14.1% | 0.01% | 0.0% |
| Q4 2016 | $392,000 | +13.3% | 4,950 | 0.0% | 0.01% | 0.0% |
| Q3 2016 | $346,000 | +80.2% | 4,950 | 0.0% | 0.01% | +50.0% |
| Q2 2016 | $192,000 | -1.0% | 4,950 | +3.1% | 0.01% | 0.0% |
| Q1 2016 | $194,000 | -54.4% | 4,800 | 0.0% | 0.01% | -57.1% |
| Q4 2015 | $425,000 | – | 4,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 94,922 | $4,063,000 | 1.33% |
| Smith, Graham & Co., Investment Advisors, LP | 277,572 | $11,880,000 | 1.05% |
| Krensavage Asset Management, LLC | 70,804 | $3,030,000 | 1.03% |
| BRANDES INVESTMENT PARTNERS, LP | 716,873 | $30,682,000 | 0.68% |
| GLOBEFLEX CAPITAL L P | 42,357 | $1,813,000 | 0.33% |
| Zebra Capital Management LLC | 6,472 | $277,000 | 0.32% |
| Capital Impact Advisors, LLC | 19,276 | $825,000 | 0.27% |
| Hein Park Capital Management LP | 31,977 | $1,369,000 | 0.26% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 195,340 | $8,361,000 | 0.25% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,027,000 | 0.15% |